The U.S. Federal Trade Commission has filed a civil
action suit against a subsidiary of Shire, PLC, as part of a
citizen petition submission regarding antibiotic Vancocin.
Shire purchased ViroPharma in January 2014 and divested
in Vancocin in August that same year. ViroPharma challenged the petitions in
2006 and 2012.
Shire said that it had no participation in these challenges, and
also said the trade commission’s actions are without merit.
Federal Trade Commission files civil action suit against Shire subsidiary
Alerts Sign-up